vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $205.4M, roughly 1.3× COLLEGIUM PHARMACEUTICAL, INC). Astera Labs, Inc. runs the higher net margin — 16.6% vs 8.3%, a 8.4% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $76.6M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 19.1%).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
ALAB vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $205.4M |
| Net Profit | $45.0M | $17.0M |
| Gross Margin | 75.6% | 62.5% |
| Operating Margin | 24.7% | 29.6% |
| Net Margin | 16.6% | 8.3% |
| Revenue YoY | 91.8% | 12.9% |
| Net Profit YoY | 82.0% | 35.3% |
| EPS (diluted) | $0.25 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $205.4M | ||
| Q3 25 | $230.6M | $209.4M | ||
| Q2 25 | $191.9M | $188.0M | ||
| Q1 25 | $159.4M | $177.8M | ||
| Q4 24 | $141.1M | $181.9M | ||
| Q3 24 | $113.1M | $159.3M | ||
| Q2 24 | $76.8M | $145.3M | ||
| Q1 24 | $65.3M | $144.9M |
| Q4 25 | $45.0M | $17.0M | ||
| Q3 25 | $91.1M | $31.5M | ||
| Q2 25 | $51.2M | $12.0M | ||
| Q1 25 | $31.8M | $2.4M | ||
| Q4 24 | $24.7M | $12.5M | ||
| Q3 24 | $-7.6M | $9.3M | ||
| Q2 24 | $-7.5M | $19.6M | ||
| Q1 24 | $-93.0M | $27.7M |
| Q4 25 | 75.6% | 62.5% | ||
| Q3 25 | 76.2% | 61.7% | ||
| Q2 25 | 75.8% | 57.7% | ||
| Q1 25 | 74.9% | 54.8% | ||
| Q4 24 | 74.0% | 54.0% | ||
| Q3 24 | 77.7% | 60.8% | ||
| Q2 24 | 77.9% | 62.5% | ||
| Q1 24 | 77.4% | 63.1% |
| Q4 25 | 24.7% | 29.6% | ||
| Q3 25 | 24.0% | 29.7% | ||
| Q2 25 | 20.7% | 18.7% | ||
| Q1 25 | 7.1% | 12.2% | ||
| Q4 24 | 0.1% | 20.9% | ||
| Q3 24 | -7.9% | 21.9% | ||
| Q2 24 | -31.7% | 32.7% | ||
| Q1 24 | -127.1% | 34.1% |
| Q4 25 | 16.6% | 8.3% | ||
| Q3 25 | 39.5% | 15.0% | ||
| Q2 25 | 26.7% | 6.4% | ||
| Q1 25 | 20.0% | 1.4% | ||
| Q4 24 | 17.5% | 6.9% | ||
| Q3 24 | -6.7% | 5.9% | ||
| Q2 24 | -9.8% | 13.5% | ||
| Q1 24 | -142.5% | 19.1% |
| Q4 25 | $0.25 | $0.48 | ||
| Q3 25 | $0.50 | $0.84 | ||
| Q2 25 | $0.29 | $0.34 | ||
| Q1 25 | $0.18 | $0.07 | ||
| Q4 24 | $1.23 | $0.36 | ||
| Q3 24 | $-0.05 | $0.27 | ||
| Q2 24 | $-0.05 | $0.52 | ||
| Q1 24 | $-1.77 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $386.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $301.7M |
| Total Assets | $1.5B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $386.7M | ||
| Q3 25 | $140.4M | $285.9M | ||
| Q2 25 | $162.3M | $222.2M | ||
| Q1 25 | $86.4M | $197.8M | ||
| Q4 24 | $79.6M | $162.8M | ||
| Q3 24 | $126.1M | $120.0M | ||
| Q2 24 | $421.1M | $271.6M | ||
| Q1 24 | $696.1M | $318.0M |
| Q4 25 | $1.4B | $301.7M | ||
| Q3 25 | $1.3B | $274.8M | ||
| Q2 25 | $1.1B | $232.2M | ||
| Q1 25 | $1.0B | $234.4M | ||
| Q4 24 | $964.8M | $228.8M | ||
| Q3 24 | $889.6M | $234.3M | ||
| Q2 24 | $845.3M | $216.6M | ||
| Q1 24 | $808.8M | $222.2M |
| Q4 25 | $1.5B | $1.7B | ||
| Q3 25 | $1.4B | $1.6B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $983.1M | $1.6B | ||
| Q2 24 | $915.5M | $1.1B | ||
| Q1 24 | $864.9M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $123.0M |
| Free Cash FlowOCF − Capex | $76.6M | $122.4M |
| FCF MarginFCF / Revenue | 28.3% | 59.6% |
| Capex IntensityCapex / Revenue | 6.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 2.12× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $123.0M | ||
| Q3 25 | $78.2M | $78.4M | ||
| Q2 25 | $135.4M | $72.4M | ||
| Q1 25 | $10.5M | $55.4M | ||
| Q4 24 | $39.7M | $84.6M | ||
| Q3 24 | $63.5M | $-9.0M | ||
| Q2 24 | $29.8M | $67.4M | ||
| Q1 24 | $3.7M | $61.9M |
| Q4 25 | $76.6M | $122.4M | ||
| Q3 25 | $65.9M | $78.3M | ||
| Q2 25 | $133.3M | $72.4M | ||
| Q1 25 | $6.0M | $54.6M | ||
| Q4 24 | $24.3M | $84.1M | ||
| Q3 24 | $46.8M | $-9.2M | ||
| Q2 24 | $28.5M | $67.1M | ||
| Q1 24 | $228.0K | $61.4M |
| Q4 25 | 28.3% | 59.6% | ||
| Q3 25 | 28.6% | 37.4% | ||
| Q2 25 | 69.5% | 38.5% | ||
| Q1 25 | 3.7% | 30.7% | ||
| Q4 24 | 17.2% | 46.2% | ||
| Q3 24 | 41.4% | -5.8% | ||
| Q2 24 | 37.1% | 46.2% | ||
| Q1 24 | 0.3% | 42.3% |
| Q4 25 | 6.9% | 0.3% | ||
| Q3 25 | 5.3% | 0.1% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 2.8% | 0.4% | ||
| Q4 24 | 10.9% | 0.3% | ||
| Q3 24 | 14.8% | 0.2% | ||
| Q2 24 | 1.7% | 0.2% | ||
| Q1 24 | 5.2% | 0.4% |
| Q4 25 | 2.12× | 7.25× | ||
| Q3 25 | 0.86× | 2.49× | ||
| Q2 25 | 2.64× | 6.05× | ||
| Q1 25 | 0.33× | 22.92× | ||
| Q4 24 | 1.61× | 6.75× | ||
| Q3 24 | — | -0.96× | ||
| Q2 24 | — | 3.44× | ||
| Q1 24 | — | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
